These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

328 related articles for article (PubMed ID: 31618698)

  • 1. Adverse Renal Response to Decongestion in the Obese Phenotype of Heart Failure With Preserved Ejection Fraction.
    Reddy YNV; Obokata M; Testani JM; Felker GM; Tang WHW; Abou-Ezzeddine OF; Sun JL; Chakrabothy H; McNulty S; Shah SJ; Lewis GD; Stevenson LW; Redfield MM; Borlaug BA
    J Card Fail; 2020 Feb; 26(2):101-107. PubMed ID: 31618698
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evidence Supporting the Existence of a Distinct Obese Phenotype of Heart Failure With Preserved Ejection Fraction.
    Obokata M; Reddy YNV; Pislaru SV; Melenovsky V; Borlaug BA
    Circulation; 2017 Jul; 136(1):6-19. PubMed ID: 28381470
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Highest Obesity Category Associated With Largest Decrease in N-Terminal Pro-B-Type Natriuretic Peptide in Patients Hospitalized With Heart Failure With Preserved Ejection Fraction.
    Vaishnav J; Chasler JE; Lee YJ; Ndumele CE; Hu JR; Schulman SP; Russell SD; Sharma K
    J Am Heart Assoc; 2020 Aug; 9(15):e015738. PubMed ID: 32750299
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characterization of the Obese Phenotype of Heart Failure With Preserved Ejection Fraction: A RELAX Trial Ancillary Study.
    Reddy YNV; Lewis GD; Shah SJ; Obokata M; Abou-Ezzedine OF; Fudim M; Sun JL; Chakraborty H; McNulty S; LeWinter MM; Mann DL; Stevenson LW; Redfield MM; Borlaug BA
    Mayo Clin Proc; 2019 Jul; 94(7):1199-1209. PubMed ID: 31272568
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Right-Sided Cardiac Dysfunction in Heart Failure With Preserved Ejection Fraction and Worsening Renal Function.
    Mukherjee M; Sharma K; Madrazo JA; Tedford RJ; Russell SD; Hays AG
    Am J Cardiol; 2017 Jul; 120(2):274-278. PubMed ID: 28528661
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Obesity and heart failure with preserved ejection fraction.
    Ternushchak TM; Tovt-Korshynska MI; Moskal OM; Kaliy VV; Griadil TI; Feysa SV
    Wiad Lek; 2024; 77(3):551-556. PubMed ID: 38691799
    [TBL] [Abstract][Full Text] [Related]  

  • 7. How B-Type Natriuretic Peptide (BNP) and Body Weight Changes Vary in Heart Failure With Preserved Ejection Fraction Compared With Reduced Ejection Fraction: Secondary Results of the HABIT (HF Assessment With BNP in the Home) Trial.
    Maisel AS; Shah KS; Barnard D; Jaski B; Frivold G; Marais J; Azer M; Miyamoto MI; Lombardo D; Kelsay D; Iqbal N; Taub PR; Kupfer K; Lee E; Clopton P; Zile M; Greenberg B
    J Card Fail; 2016 Apr; 22(4):283-93. PubMed ID: 26433086
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prevalence, Profile, and Prognosis of Severe Obesity in Contemporary Hospitalized Heart Failure Trial Populations.
    Joyce E; Lala A; Stevens SR; Cooper LB; AbouEzzeddine OF; Groarke JD; Grodin JL; Braunwald E; Anstrom KJ; Redfield MM; Stevenson LW;
    JACC Heart Fail; 2016 Dec; 4(12):923-931. PubMed ID: 27908391
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Echocardiographic and Hemodynamic Parameters Associated with Diminishing Renal Filtration among Patients with Heart Failure with Preserved Ejection Fraction.
    Lo KB; Mezue K; Ram P; Goyal A; Shah M; Krishnamoorthy P; Gupta S; Pressman GS; Rangaswami J
    Cardiorenal Med; 2019; 9(2):83-91. PubMed ID: 30544108
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Associations With and Prognostic and Discriminatory Role of N-Terminal Pro-B-Type Natriuretic Peptide in Heart Failure With Preserved Versus Mid-range Versus Reduced Ejection Fraction.
    Savarese G; Orsini N; Hage C; Dahlström U; Vedin O; Rosano GMC; Lund LH
    J Card Fail; 2018 Jun; 24(6):365-374. PubMed ID: 29597053
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pro-Inflammatory Biomarkers in Stable Versus Acutely Decompensated Heart Failure With Preserved Ejection Fraction.
    Abernethy A; Raza S; Sun JL; Anstrom KJ; Tracy R; Steiner J; VanBuren P; LeWinter MM
    J Am Heart Assoc; 2018 Apr; 7(8):. PubMed ID: 29650706
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Influence of renal dysfunction phenotype on mortality in decompensated heart failure with preserved and mid-range ejection fraction.
    Casado J; Sánchez M; Garcés V; Manzano L; Cerqueiro JM; Epelde F; García-Escrivá D; Pérez-Silvestre J; Morales JL; Montero-Pérez-Barquero M;
    Int J Cardiol; 2017 Sep; 243():332-339. PubMed ID: 28528982
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical characteristics and prognostic influence of renal dysfunction in heart failure patients with preserved ejection fraction.
    Casado J; Montero M; Formiga F; Carrera M; Urrutia A; Arévalo JC; Pérez-Calvo JI;
    Eur J Intern Med; 2013 Oct; 24(7):677-83. PubMed ID: 23830876
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of Empagliflozin as an Add-On Therapy on Decongestion and Renal Function in Patients With Diabetes Hospitalized for Acute Decompensated Heart Failure: A Prospective Randomized Controlled Study.
    Tamaki S; Yamada T; Watanabe T; Morita T; Furukawa Y; Kawasaki M; Kikuchi A; Kawai T; Seo M; Abe M; Nakamura J; Yamamoto K; Kayama K; Kawahira M; Tanabe K; Fujikawa K; Hata M; Fujita Y; Umayahara Y; Taniuchi S; Sanada S; Shintani A; Fukunami M
    Circ Heart Fail; 2021 Mar; 14(3):e007048. PubMed ID: 33663235
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Outcomes and worsening renal function in patients hospitalized with heart failure with preserved ejection fraction.
    Sharma K; Hill T; Grams M; Daya NR; Hays AG; Fine D; Thiemann DR; Weiss RG; Tedford RJ; Kass DA; Schulman SP; Russell SD
    Am J Cardiol; 2015 Nov; 116(10):1534-40. PubMed ID: 26410603
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of Prognostic Usefulness of Serum Insulin-Like Growth Factor-Binding Protein 7 in Patients With Heart Failure and Preserved Versus Reduced Left Ventricular Ejection Fraction.
    Hage C; Bjerre M; Frystyk J; Gu HF; Brismar K; Donal E; Daubert JC; Linde C; Lund LH
    Am J Cardiol; 2018 Jun; 121(12):1558-1566. PubMed ID: 29622288
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interaction Between Spironolactone and Natriuretic Peptides in Patients With Heart Failure and Preserved Ejection Fraction: From the TOPCAT Trial.
    Anand IS; Claggett B; Liu J; Shah AM; Rector TS; Shah SJ; Desai AS; O'Meara E; Fleg JL; Pfeffer MA; Pitt B; Solomon SD
    JACC Heart Fail; 2017 Apr; 5(4):241-252. PubMed ID: 28359411
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Optimizing The Management of Obese HFpEF Phenotype: Can We Mind Both The Heart and The Kidney?
    Upadhya B; Amjad A; Stacey RB
    J Card Fail; 2020 Feb; 26(2):108-111. PubMed ID: 31759161
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prevalence, clinical phenotype, and outcomes associated with normal B-type natriuretic peptide levels in heart failure with preserved ejection fraction.
    Anjan VY; Loftus TM; Burke MA; Akhter N; Fonarow GC; Gheorghiade M; Shah SJ
    Am J Cardiol; 2012 Sep; 110(6):870-6. PubMed ID: 22681864
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Changes in natriuretic peptides after acute hospital presentation for heart failure with preserved ejection fraction: A feasible surrogate trial endpoint? A report from the prospective Karen study.
    Savarese G; Donal E; Hage C; Oger E; Persson H; Daubert JC; Linde C; Lund LH;
    Int J Cardiol; 2017 Jan; 226():65-70. PubMed ID: 27788392
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.